You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

stage II pancreatic cancer

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Recurrent Glioblastoma, Refractory Glioblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory

Recruiting
  • Recurrent Glioblastoma
  • Refractory Glioblastoma
  • IL13Ralpha2-specific Hinge-optimized 4-1BB-co-stimulatory CAR/Truncated CD19-expressing Autologous TN/MEM Cells
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 29, 2021

Cystitis Trial in Moscow (Monural, UroNext)

Completed
  • Cystitis
  • Moscow, Russian Federation
    Urology Clinic of Moscow State University of Medicine and Dentis
Jul 6, 2023

Parkinson Disease Trial in Hong Kong (Mind-body interventions)

Active, not recruiting
  • Parkinson Disease
  • Mind-body interventions
  • Hong Kong, Hong Kong
    2/F., The Hong Kong Jockey Club Building for Interdisciplinary R
Oct 5, 2023

Breast Cancer, Obesity, Morbid Trial in Istanbul (mammography)

Not yet recruiting
  • Breast Cancer
  • Obesity, Morbid
  • mammography
  • Istanbul, Turkey
    Fatih Sultan Mehmet Research and Training Hospital
Dec 8, 2022

Autism, Autism Spectrum Disorder Trial in Durham (Cord Tissue Mesenchymal Stromal Cells, Placebo Infusion)

Active, not recruiting
  • Autism
  • Autism Spectrum Disorder
  • Cord Tissue Mesenchymal Stromal Cells
  • Placebo Infusion
  • Durham, North Carolina
    Duke University Medical Center
Oct 26, 2022

Hemophilia A Trial in Worldwide (efanesoctocog alfa (BIVV001))

Recruiting
  • Hemophilia A
  • efanesoctocog alfa (BIVV001)
  • Los Angeles, California
  • +64 more
Jul 12, 2022

Yoga Program for Improving Quality of Life in Couples Coping

Recruiting
  • Esophageal Carcinoma
  • +3 more
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 26, 2021

Mantle Cell Lymphoma Trial in United States (bortezomib)

Active, not recruiting
Has Results
  • Mantle Cell Lymphoma
  • San Francisco, California
  • +47 more
Aug 16, 2021

Progress of Labor

Not yet recruiting
  • Progress pf Labor
  • ultrasound
  • (no location specified)
Apr 9, 2023

End-stage Renal Disease Trial (Xeltis Hemodialysis Access (aXess) graft)

Not yet recruiting
  • End-stage Renal Disease
  • Xeltis Hemodialysis Access (aXess) graft
  • (no location specified)
Jul 21, 2022

Risk Factors for Post Whipple Pancreatic Fistula

Completed
  • Pancreatic Fistula
  • pancreaticoduodenectomy
  • (no location specified)
Aug 14, 2021

Prostate Cancer, PET/CT Trial in Hefei ([68Ga]Ga-PSMA-D5, [68Ga]Ga-PSMA-11)

Recruiting
  • Prostate Cancer
  • PET/CT
  • Hefei, Anhui, China
    The First Affiliated Hospital of China University of Science and
Jul 19, 2023

Obesity Trial in Cary (Fundic Ablation in Combination with Endoscopic Sleeve Gastroplasty, Fundic Mucosal Ablation with ERBE

Not yet recruiting
  • Obesity
  • Fundic Ablation in Combination with Endoscopic Sleeve Gastroplasty
  • +2 more
  • Cary, North Carolina
    True You Weight Loss
Aug 8, 2023

Glycotest™ HCC Panel vs AFP for Detection of Early-stage

Recruiting
  • Carcinoma, Hepatocellular
  • Cirrhosis, Liver
    • Los Angeles, California
    • +19 more
    Mar 14, 2022

    Pancreatic Adenocarcinoma Trial in Louisville (Nestle IMPACT Advanced Recovery, Nestle Boost High Protein Drink)

    Terminated
    • Pancreatic Adenocarcinoma
    • Nestle IMPACT Advanced Recovery
    • Nestle Boost High Protein Drink
    • Louisville, Kentucky
      University of Louisville
    Jul 10, 2021

    Somatic Mosaicism in Twins Discordant for Childhood Cancer

    Not yet recruiting
    • Pediatric Central Nervous System Tumor
    • +3 more
    • Biospecimen collection
    • Questionnaire Administration
    • (no location specified)
    Sep 19, 2023

    Lung Cancer, Non-Small Cell Trial in Worldwide (Dostarlimab, Pembrolizumab, Chemotherapy)

    Active, not recruiting
    • Lung Cancer, Non-Small Cell
    • Lone Tree, Colorado
    • +65 more
    Jun 26, 2022

    Cancer, Prostate Cancer, Colorectal Cancer Trial in Reykjavik (A digital solution for patients with Cancer, Standard of care for

    Recruiting
    • Cancer
    • +3 more
    • A digital solution for patients with Cancer
    • Standard of care for patients with Cancer
    • Reykjavik, Iceland
    • +1 more
    Apr 9, 2023

    Vaginal Bleeding, Loop Electrosurgical Excision Trial in Mentese, Mugla (Chitosan)

    Recruiting
    • Vaginal Bleeding
    • Loop Electrosurgical Excision
    • Menteşe, Muğla, Turkey
    • +1 more
    Dec 21, 2022

    Diabetes Trial in Chengdu (INS062 injection, Insulin Aspart, HR20014 injection)

    Recruiting
    • Diabetes
    • INS062 injection
    • +3 more
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Feb 8, 2023

    Ovarian Tumors, Sarcopenia Trial in Chambéry (Sarcopenia diagnostic test)

    Recruiting
    • Ovarian Neoplasms
    • Sarcopenia
    • Sarcopenia diagnostic test
    • Chambéry, Savoie, France
      Centre Hospitalier Metropole Savoie
    Apr 17, 2023

    ACL - Anterior Cruciate Ligament Deficiency, Varus Deformity of Tibia (Disorder), ACL Injury Trial in Cairo (medial opening

    Completed
    • ACL - Anterior Cruciate Ligament Deficiency
    • +3 more
    • medial opening wedge high tibial osteotomy
    • anterior cruciate ligament reconstruction
    • Cairo, Egypt
      Ain Shams University Hospitals
    Apr 5, 2023

    Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia Trial in Columbus (drug, biological, other)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Refractory Chronic Lymphocytic Leukemia
    • Bcl-2 Inhibitor GDC-0199
    • +5 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Oct 29, 2021

    Colorectal Cancer Stage IV, No Evidence of Disease State Trial in Genova (Durvalumab Injection for intravenous use 500 mg vial

    Recruiting
    • Colorectal Cancer Stage IV
    • No Evidence of Disease State
    • Durvalumab Injection for intravenous use 500 mg vial solution for infusion
    • Regorafenib 30 mg capsules
    • Genova, Liguria, Italy
      IRCCS Ospedale Policlinico San Martino
    May 16, 2022

    Malignant Melanoma Trial in Aurora (Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab)

    Recruiting
    • Malignant Melanoma
    • Oral Decitabine/Cedazuridine (DEC-C) in Combination with Nivolumab
    • Aurora, Colorado
      University of Colorado Hospital
    May 25, 2022